Pathway Mechanism of Potential Genomic Markers of Dipeptidyl Peptidase-4 Inhibitor Treatment Response in Type 2 Diabetes

被引：0

作者：

Jamaluddin, J. L. ^{[1
]}

Huri, H. Z. ^{[1
]}

Vethakkan, S. R. ^{[2
]}

Mustafa, N. ^{[2
]}

Ahmad, W. A. W. ^{[2
]}

机构：

[1] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur 50603, Malaysia

[2] Univ Malaya, Med Ctr, Clin Invest Ctr, Kuala Lumpur 59100, Malaysia

来源：

PUBLIC HEALTH GENOMICS | 2015年 / 18卷

关键词：

D O I：

暂无

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

P005

引用

页码：9 / 9

页数：1

共 50 条

[1] Vildagliptin, a dipeptidyl peptidase-4 inhibitor, for the treatment of type 2 diabetes
Stein, Stephanie A.
Lamos, Elizabeth M.
Davis, Stephen N.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2014, 10 (04) : 599 - 608
[2] Linagliptin, a dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes
Tiwari, Atul
CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2009, 10 (10) : 1091 - 1104
[3] Saxagliptin: A dipeptidyl peptidase-4 inhibitor in the treatment of type 2 diabetes mellitus
Dave, Darshan J.
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2011, 2 (04) : 230 - 235
[4] Saxagliptin: a new dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes
Deacon, Carolyn F.
Holst, Jens J.
ADVANCES IN THERAPY, 2009, 26 (05) : 488 - 499
[5] Saxagliptin: A dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes mellitus
Neumiller, Joshua J.
Campbell, R. Keith
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (18) : 1515 - 1525
[6] Saxagliptin: a new dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes
Carolyn F. Deacon
Jens J. Holst
Advances in Therapy, 2009, 26 : 488 - 499
[7] Dutogliptin, a dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes mellitus
Johnson, Kathryn M. S.
CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2010, 11 (04) : 455 - 463
[8] Clinical and genetic predictors of dipeptidyl peptidase-4 inhibitor treatment response in Type 2 diabetes mellitus
Jamaluddin, Jazlina Liza
Huri, Hasniza Zaman
Vethakkan, Shireene Ratna
PHARMACOGENOMICS, 2016, 17 (08) : 867 - 881
[9] Saxagliptin A New Dipeptidyl Peptidase-4 Inhibitor for Type 2 Diabetes
Lam, Sum
Saad, Maha
CARDIOLOGY IN REVIEW, 2010, 18 (04) : 213 - 217
[10] Pancreatic gene variants potentially associated with dipeptidyl peptidase-4 inhibitor treatment response in Type 2 diabetes
Jamaluddin, Jazlina Liza
Huri, Hasniza Zaman
Vethakkan, Shireene Ratna
Mustafa, Norlaila
PHARMACOGENOMICS, 2014, 15 (02) : 235 - 249

← 1 2 3 4 5 →